Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

34.79
Delayed Data
As of 4:01pm ET
 -1.00 / -2.79%
Today’s Change
25.27
Today|||52-Week Range
263.81
-65.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues2.2B2.7B2.8B2.8B
 
 
 
 
 
Cost of Goods Sold532.9M635.5M601.0M737.0M
 
 
 
 
 
Depreciation And Amortization407.0M635.0M700.4M--
 
 
 
 
 
Operating ExpensesGross Income1.3B1.5B1.5B2.1B
 
 
 
 
 
General Expenses629.6M766.6M799.2M821.7M
 
 
 
 
 
Other Operating Expenses6.1M176.9M5.2M817.4M
 
 
 
 
 
Research And Development55.8M81.1M101.6M95.9M
 
 
 
 
 
Total Operating Expenses1.6B2.2B2.1B2.4B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income615.3M518.4M681.0M412.6M
 
 
 
 
 
Extraordinary Charge-91.9M-176.9M-233.2M-190.7M
 
 
 
 
 
Interest Expense On Debt297.8M412.7M420.2M431.7M
 
 
 
 
 
Other Expenses-71.1M5.6M-34.0M-3.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income155.4M-64.7M-5.7M-213.1M
 
 
 
 
 
Income Taxes-80.9M-13.1M-57.4M-123.8M
 
 
 
 
 
Minority Interest-800.0K-1.4M-2.2M-500.0K
 
 
 
 
 
Net Income73.7M-53.0M49.5M-336.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS336.8M344.4M344.9M344.9M
 
 
 
 
 
Shares To Calculate EPS Diluted343.4M344.4M351.0M344.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.22-$0.15$0.14-$0.98
 
 
 
 
 
EPS Diluted$0.21-$0.15$0.14-$0.98